friday, october 20 tokyo international forum os:oral sessionjshem79.jp/en/schedule_e.pdf · 2017....
TRANSCRIPT
10
50
20
50
15 00
E E
E
E
E
E E
E
E
E E
E
E
E
E
EE
EE
E
E
E
EL1-12 EL1-13 EL1-14
EL1-16 EL1-17 EL1-18 SEL1-19
OS1-4CMDS:Basic Science 1Chair:Hiromichi Matsushita
OS1-7C OS1-7D
OS1-8C OS1-8D
OS1-9CCongenital AnemiaChair:Hiroshi Yagasaki
OS1-9D
OS1-10C OS1-10D
Poster Discussion(17:30~18:30)
Poster Removal(18:30~19:30)
OS1-12D
OS1-13COS1-13DInfection 1
Chair:Nobu Akiyama
ExcellentCase Report 2
ExcellentCase Report 1
OS1-14C OS1-14D
OS1-15D
OS1-6C OS1-6D
OS1-12C
OS1-15C
OS1-11CMolecular Pathogenesis
in MyelomaChair:Naoya Mimura
OS1-11DMultiple Myeloma:Molecular TargetChair:Jiro Kikuchi
OS1-4D
Special Educational Lecture SEL1-15Chair:Kiyohiko HataSpeaker:Steven P. Treon
PresidentialLecture
JSHBusinessMeeting
OpeningCeremony
Special LectureChair:Masahiro KizakiSpeaker:H. Phillip Koeffler
IS1Chugai Pharmaceutical Co., Ltd.
IS2Janssen
PharmaceuticalK.K.
IS3ONO
PHARMACEUTICALCO., LTD.
Symposium 3
Presidential SymposiumYoung Japanese Hematologists in the World: molecularpathogenesis of leukemia and leukemic stem cell (LSC)
Chairs:Scott A. Armstrong, Stephen D. Nimer
Poster Viewing(11:00~17:30)
Poster①:Hall Building Hall E, B2FPoster②:Glass Building Lounge, 7F
Hall Building Hall E, B2FB5 lobby, 5F
Glass Building G404, 4FG504, 5F
Exhibition & Corporate Partner Lounge(9:00~18:30)
EL1-1
EL1-5
SEL1-9 SEL1-10 SEL1-11
OS1-6BMyeloma Microenvironment
Chair:Masahiro Abe
OS1-7AGenetic Analysis of AMLChair:Masashi Sanada
OS1-7BMolecular Target of AMLChair:Susumu Goyama
OS1-8A OS1-8B
OS1-9A OS1-9B
OS1-10BMalignant Lymphoma:Genomic ResearchChair:Akihiro Tomita
OS1-11A OS1-11B
OS1-12A OS1-12B
OS1-13A OS1-13B
OS1-14B
OS1-6ANovel Therapy, MRD, andImmuno-Monitoring in MM
Chair:Yoichi Imai
OS1-10A
EL1-2
EL1-6
EL1-3
EL1-7
Special Educational Lecture SEL1-4Chair:Masafumi TaniwakiSpeaker:Shaji Kumar
Special Educational Lecture SEL1-8Chair:Kensei TobinaiSpeaker:Steven M. Horwitz
EHA Special LectureChair:Yuzuru KanakuraSpeaker:Pieter Sonneveld
LS1-2ONO PHARMACEUTICAL
CO., LTD./Bristol-Myers Squibb K.K.
LS1-3CSL Behring K.K.
LS1-4Kyowa Hakko Kirin
Co., Ltd.
LS1-13Takeda PharmaceuticalCompany Limited
LS1-5Bristol-Myers Squibb
K.K.
LS1-6Novartis Pharma K.K.
LS1-7Janssen Pharmaceutical
K.K.
LS1-9SymBio PharmaceuticalsLimited/Eisai Co.,Ltd.
LS1-12Shire Japan KK
LS1-8Pfizer Japan Inc.
LS1-10MSD K.K.
LS1-11Fuji Pharma Co.,Ltd.
LS1-14Daiichi Sankyo Co., Ltd.
LS1-15Astellas Pharma Inc.
Symposium 1Control of immune microenvironment in tumor
Chairs:Yoshiki Akatsuka, Hiroshi Fujiwara
Symposium 2Anemia and Ineffective Erythropoiesis
Chairs:Hideo Harigae, Etsuro Ito
Poster Mounting(8:00~11:00)
Exhibition & Corporate Partner Lounge(9:00~18:30)
Poster Viewing(11:00~17:30)
20 3514:00 15:00 16:00 17:00 18:00 19:00 20:00
E Lectures in English
EL:Educational LectureSEL:Special Educational LectureOS:Oral Session
LISS:Luncheon Seminar:Industry Session
14:00 15:00 16:00 17:00 18:00 19:00 20:00
10 4045 15 55 1013:0012:0011:0010:009:008:00
No.1(Hall C 4F)
No.2(Hall B7(1)7F)
No.3(Hall B7(2)7F)
No.4(Hall B5(1)5F)
No.5(Hall B5(2)5F)
No.6(Hall D7 7F)
No.7(Hall D5 5F)
No.8(Hall D1 1F)
No.9(G402 4F)
No.10(G409 4F)
No.11(G502 5F)
No.12(G510 5F)
No.13(G602 6F)
No.14(G610 6F)
No.15(G701 7F)
Poster
Exhibition
No.16(Seminar Room 1 B2F)
No.17(Seminar Room 2 B2F)
Hall Building
Glass Building
B2F
Day 1 Friday, October 20
13:0012:0011:0010:009:008:00
Tokyo International Forum10 20
10 10
50
15 004500
7:30
EE
E
E
E
E
E
E
Re Re Re Re
ReReReRe
E
E
E E
E
EE
E
E
E
E
E
EE
Re Re Re Re
Re Re Re
Re Re Re Re
E
E
Poster Discussion(17:10~18:10)
PosterRemoval
(18:10~18:40)
ExcellentCase Report 4
ExcellentCase Report 3
Special Educational Lecture SEL2-12Chair:Masao TomonagaSpeaker:Stephen D. Nimer
Plenary SessionChairs:Itaru Matsumura, Takanori Teshima
JSH-EHA Joint Symposium (Symposium 5)Novel treatment strategy for MM using novel drugs in
combination with immune modulationChairs:Pieter Sonneveld, Shinsuke Iida
Symposium 6New world of innate immunity:Novel ontogeny and functions
Chairs:Toshio Kitamura, Yoshio Katayama
SHI (Socio-Hematology Issues) Symposium 2
EL2-9
EL2-13
SEL2-17 SEL2-18
EL2-14 EL2-15 EL2-16
SEL2-19
EL2-10 EL2-11
Special Educational Lecture SEL1-15Chair:Kiyohiko HataSpeaker:Steven P. Treon
EL1-16 EL1-17 EL1-18
EL1-12 EL1-13 EL1-14
SEL1-19
OS2-11D
Reception for all theparticipants18:45 ~ 20:30Imperial Hotel TokyoFuji Room, 3F
E
E
Scientific Exchange TrainingProgram(SETP) 7:30 ~ 8:30
SETP1"Lymphoma"Commentator:Wyndham WilsonModerator:Koji Izutsu
SETP2"Myelodysplastic Syndromes"Commentator:Rafael BejarModerator:Hironori Harada
OS2-6C OS2-6D
OS2-9CMPN:Basic Science 1
Chair:Osamu Miura
OS2-9D
OS2-10COS2-10D
CML:Basic Science 2Chair:Tetsuzo Tauchi
OS2-8C OS2-8D
OS2-11C
OS2-12COS2-12D
Thromboisis and HemostasisChair:Tadashi Matsushita
OS2-13C OS2-13D
OS2-14C OS2-14D
OS2-15C OS2-15D
Poster Viewing(11:00~17:10)
Poster①:Hall Building Hall E, B2FPoster②:Glass Building Lounge, 7F
Hall Building Hall E, B2FB5 lobby, 5F
Glass Building G404, 4FG504, 5F
Exhibition & Corporate Partner Lounge(9:00~18:30)
Poster Mounting(8:00~11:00)
ASH Special LectureChair:Kinuko MitaniSpeaker:Kenneth C. Anderson
LS2-2Takeda PharmaceuticalCompany Limited
MS2-2Chugai Pharmaceutical
Co., Ltd.
LS2-3Celgene K.K.
MS2-3Celgene K.K.
LS2-4NIPPON SHINYAKU
CO., LTD.
MS2-4Kyowa Hakko Kirin
Co., Ltd.
LS2-5Janssen Pharmaceutical
K.K.
MS2-5Janssen Pharmaceutical
K.K.
LS2-6Novartis Pharma K.K.
MS2-6Novartis Pharma K.K.
LS2-7Zenyaku Kogyo Co., Ltd.
MS2-7MSD K.K.
LS2-8Alexion Pharma G.K.
LS2-9Bristol-Myers Squibb K.K.
MS2-9Pfizer Japan Inc.
LS2-10Sanofi K.K.
MS2-10Otsuka Pharmaceutical
Co., Ltd.
LS2-11SymBio PharmaceuticalsLimited/Eisai Co.,Ltd.
MS2-11Bristol-Myers Squibb K.K.
LS2-12SHIONOGI & CO., LTD.
MS2-12Shire Japan KK
LS2-13Asahi Kasei PharmaCorporation
MS2-13ONO PHARMACEUTICAL
CO., LTD.
LS2-14Baxalta Japan Ltd.
MS2-14mundipharma K.K.
LS2-15Meiji Seika Pharma
Co.,Ltd
Symposium 4Cutting-edge of basic and clinical research for
malignant lymphomaChairs:Kunihiro Tsukasaki, Hirokazu Nagai
SHI (Socio-Hematology Issues) Symposium 1
Asian Joint Panel DiscussionMDS/MPN:progress of basic and clinical research in Asia
Chairs:Hyeoung-Joon Kim, Norio Komatsu
EL2-1 EL2-2 EL2-3 SEL2-4
EL2-5 EL2-6 EL2-7 SEL2-8
Special Educational Lecture SEL1-4Chair:Masafumi TaniwakiSpeaker:Shaji Kumar
Special Educational Lecture SEL1-8Chair:Kensei TobinaiSpeaker:Steven M. Horwitz
EL1-1
EL1-5 EL1-6 EL1-7
SEL1-9 SEL1-10 SEL1-11
EL1-2 EL1-3
OS2-9A
OS2-10B
OS2-4A
OS2-6A OS2-6B
OS2-9B
OS2-10A
OS2-11A OS2-11B
OS2-12APediatric Hematology 1Chair:Takeshi Taketani
OS2-12BPediatric Hematology 2Chair:Masahiro Hirayama
OS2-13A OS2-13B
OS2-14A OS2-14B
OS2-8A OS2-8B
OS2-4B
Exhibition & Corporate Partner Lounge(9:00~18:30)
Poster Viewing(11:00~17:10)
SETP1"Lymphoma"
SETP2"MyelodysplasticSyndromes"
40 501014:00 15:00 16:00 17:00 18:00 19:00 20:00
EReplayLectures in English
ReEL:Educational LectureSEL:Special Educational LectureOS:Oral Session
:Luncheon Seminar:Morning SeminarSSLM
14:00 15:00 16:00 17:00 18:00 19:00 20:00
201013:0012:0011:0010:009:008:00
No.1(Hall C 4F)
No.2(Hall B7(1)7F)
No.3(Hall B7(2)7F)
No.4(Hall B5(1)5F)
No.5(Hall B5(2)5F)
No.6(Hall D7 7F)
No.7(Hall D5 5F)
No.8(Hall D1 1F)
No.9(G402 4F)
No.10(G409 4F)
No.11(G502 5F)
No.12(G510 5F)
No.13(G602 6F)
No.14(G610 6F)
No.15(G701 7F)
Poster
Exhibition
No.16(Seminar Room 1 B2F)
No.17(Seminar Room 2 B2F)
B2F
Hall Building
Glass Building
Day 2 Saturday, October 21
13:0012:0011:0010:009:008:00
Tokyo International Forum
20
1025
7:30
4500
E
E
E
E
EE
E
EE
E
EE
E
EEE
Re Re Re
Re Re Re
Re
Re
Re
E
E
E
EE
EE
EE
E
E
Re Re
Re Re Re
Re Re Re ReE
E
SEL2-4
EL2-13 EL2-14 EL2-15 EL2-16
EL2-1 EL2-2 EL2-3
OS3-4D
OS3-9DOS3-9C
OS3-8C
OS3-10DCLL
Chair:Yukio Kobayashi
OS3-10CALL:Basic Research 3Chair:Toshihiko Imamura
OS3-11DOS3-11C
OS3-13DOS3-13C
OS3-14DOS3-14C
OS3-12CTreatment for Refractory Multiple Myeloma 1:Daratumumab (POLLUX) ,Elotuzumab etc.
Chair:Shigeki Ito
OS3-12DTreatment for Refractory Multiple Myeloma 2:
Daratumumab (CASTOR) ,etc.Chair:Tadao Ishida
OS3-15CMolecular Mechanismof Leukemogenesis 1Chair:Yasuhiko Kamikubo
OS3-15DMolecular Mechanismof Leukemogenesis 2 Chair:Toshiya Inaba
OS3-8D
EL3-8 EL3-9
EL3-12
SEL3-16
EL3-13 EL3-14 EL3-15
EL3-10 SEL3-11
Symposium 10GVHD:A bench-to-bedside update
Chairs:Makoto Murata, Junya Kanda
Public Symposium
SHI (Socio-Hematology Issues) Symposium 4
SHI (Socio-Hematology Issues) Symposium 1
Symposium 9Myeloid neoplasia and clinical sequence
Chairs:Seishi Ogawa, Yasushi Miyazaki
E
E
Scientific Exchange TrainingProgram(SETP) 7:30 ~ 8:30
SETP3"Multiple Myeloma"Commentator:Kenneth C. Anderson,Moderator:Junya Kuroda
SETP4"Acute Myeloid Leukemia/LeukemicStem Cell"Commentator:Scott A. ArmstrongModerator:Yoichi Imai
Exhibition & Corporate Partner Lounge(9:00~15:30)
Best Poster Viewing(8:00~15:30)
Closing
Ceremony
Special EducationalLecture SEL2-12Chair:Masao TomonagaSpeaker:Stephen D. Nimer
MS3-2Janssen Pharmaceutical
K.K.
LS3-2Chugai
PharmaceuticalCo., Ltd.
MS3-3Novartis Pharma K.K.
LS3-3Janssen
PharmaceuticalK.K.
MS3-4Pfizer Japan Inc.
LS3-4Fujimoto
PharmaceuticalCorp.
MS3-5Sumitomo Dainippon Pharma
Co., Ltd.Oncology Medical Affairs
LS3-5Otsuka
PharmaceuticalCo., Ltd.
MS3-6Sanofi K.K.
LS3-6Novo NordiskPharma Ltd.
MS3-7Astellas Pharma Inc.
LS3-7Pfizer Japan Inc.
LS3-8Bayer Yakuhin, Ltd.
MS3-9Bristol-Myers Squibb
K.K.
LS3-9Gilead Sciences
MS3-10Takeda PharmaceuticalCompany Limited
MS3-11Medical Division,Eisai Co., Ltd.
LS3-10Sumitomo
Dainippon PharmaCo., Ltd.
LS3-11AbbVie GK
MS3-12ONO PHARMACEUTICAL
CO., LTD.
LS3-12Bioverativ Japan
Ltd.
MS3-13CSL Behring K.K.
LS3-13mundipharma K.K.
LS3-14JCR
PharmaceuticalsCo., Ltd
LS3-15Sanofi K.K.
EL3-1 EL3-2
SEL3-5 SEL3-6
EL2-9 EL2-10 EL2-11
SEL2-17 SEL2-18 SEL2-8
EL2-7 EL2-6
EL3-3 SEL3-4
OS3-4BOS3-4A
OS3-7BOS3-7A
OS3-9BAnemia in AsiaChair:Hitoshi Kanno
OS3-9AErythropoiesis 2Chair:Daisuke Sugiyama
OS3-10BOS3-10A
OS3-11BOS3-11A
OS3-12A
OS3-13BOS3-13A
OS3-14BCML:Clinical StudyChair:Hiroshi Matsuoka
OS3-14A
OS3-15BOS3-15A
OS3-8BB Cell Lymphoma,Clinical Research 2Chair:Tomohiro Kinoshita
OS3-12BTransplant Outcome
and OthersChair:Yasuhiro Okamoto
OS3-8APTCL:Pathogenesis and
Treatment 2Chair:Yoshitaka Imaizumi
JSH AwardLecture
Special EducationalLecture SEL3-7
Chair:Tomoki NaoeSpeaker:Christine Chomienne
JSH-ASH Joint Symposium (Symposium 7)New insights into AML biologyChairs:Kenneth C. Anderson, Koichi Akashi
Symposium 8
SHI (Socio-Hematology Issues) Symposium 3
Best Poster Viewing(8:00~15:30)
Hall Building Hall E, B2F
Hall Building Hall E, B2FB5 lobby, 5F
Glass Building G404, 4FG504, 5F
Exhibition & Corporate Partner Lounge(9:00~15:30)
SETP3"Multiple Myeloma"
SETP4"Acute Myeloid Leukemia/Leukemic Stem Cell"
20 20 4514:00 15:00 16:00 17:00 18:00 19:00 20:00
EReplayLectures in English
ReEL:Educational LectureSEL:Special Educational LectureOS:Oral Session
:Luncheon Seminar:Morning SeminarSSLM
14:00 15:00 16:00 17:00 18:00 19:00 20:00
25 101013:0012:0011:0010:009:008:00
Poster
Exhibition
No.1(Hall C 4F)
No.2(Hall B7(1)7F)
No.3(Hall B7(2)7F)
No.4(Hall B5(1)5F)
No.5(Hall B5(2)5F)
No.6(Hall D7 7F)
No.7(Hall D5 5F)
No.8(Hall D1 1F)
No.9(G402 4F)
No.10(G409 4F)
No.11(G502 5F)
No.12(G510 5F)
No.13(G602 6F)
No.14(G610 6F)
No.15(G701 7F)
No.16(Seminar Room 1 B2F)
No.17(Seminar Room 2 B2F)
Hall Building
Glass Building
B2F
Educational LectureReplay Booth ①(Hall E B2F)
Educational LectureReplay Booth ②(Hall E B2F)
Day 3 Sunday, October 22
13:0012:0011:0010:009:008:00
Tokyo International Forum